Search results
Here are four reasons Medicare drug-price "negotiation" in NJ isn't truly a negotiation.
App.com | Asbury Park Press via Yahoo News· 2 hours agoNew data show these private negotiations have led to discounts of 53% off list prices on average....
Analysis | Weight-loss drugs are so popular they’re headed for Medicare negotiations
Washington Post· 6 days agoToday’s edition: Conservative policymakers with ties to former president Donald Trump want to limit...
The Zacks Analyst Blog Highlights Biogen, Eli Lilly's, Prothena and AC Immune
Zacks via Yahoo Finance· 4 hours agoLilly and Biogen carry a Zacks Rank #3 (Hold) each. You can see the complete list of today’s Zacks...
Best Medicare Advantage Plans in Florida 2024 - NerdWallet
Nerdwallet· 5 days agoNearly two dozen providers sell Medicare Advantage plans in Florida. Find out which ones are the top...
$2,000 Cap On Out-Of-Pocket Drug Costs To Help Millions Of Medicare Beneficiaries
Forbes· 9 hours agoThe Inflation Reduction Act’s cap of $2,000 on annual out-of-pocket spending on outpatient drugs...
Bernie Sanders Wants to Subpoena Novo Nordisk Over Wegovy’s Price. What to Know.
Barrons.com· 22 hours agoThose list prices are significantly higher than the list prices of the same medicines in other...
Donald Trump back in Washington for meetings with vice presidential contenders, congressional allies...
CNN via Yahoo News· 1 hour agoFormer President Donald Trump is back in Washington for the first time since becoming the...
Medicare changes will impact your wallet in 2025
TheStreet.com· 7 days agoThe Centers for Medicare and Medicaid Services is making important changes next year. There are many concerns Americans regularly confront about their retirement years. The ...
Got Questions About Medicare Hospice Services? Here Are Some Answers
Forbes· 2 days agoThere is one subject that rarely comes up when it comes to Medicare: hospice, end-of-life care for...
Michigan’s largest insurer to drop weight-loss drug coverage
Chicago Tribune· 21 hours agoWeight-loss drugs from Novo Nordisk A/S and Eli Lilly & Co. will lose coverage under many plans run...